The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Isolation of High Avidity Melanoma-Reactive CTL from Heterogeneous Populations Using Peptide-MHC Tetramers
Abstract
Immunogenic peptides of human tumor Ag have been used to generate antigen-specific CTL. However, the vast majority of these peptide-specific CTL clones are of low avidity and are peptide, but not tumor, reactive. Peptide-MHC tetramers have been shown to bind specific TCRs with sufficient affinity to be useful reagents for flow cytometry. In this paper we demonstrate that peptide-MHC tetramers can also be used to selectively identify high avidity tumor-reactive CTL and enrich, from a heterogeneous population, the subpopulation of peptide-reactive T cells that can lyse tumor targets. The melanoma proteins, MART-1 and gp100, were used to induce potentially tumor-reactive T cells, and the intensity of T cell staining by TCR binding of specific peptide-MHC tetramers was assessed. A range of fluorescence intensity was detected, and the magnitude of tetramer binding was correlated with T cell avidity. The population of peptide-reactive T cells was phenotypically similar with regard to expression of TCR and adhesion molecules, suggesting that this differential avidity for tumor cells reflected differential affinity of the TCR for its peptide-MHC ligand. Sorting, cloning, and expansion of tetramerhigh CTL from a heterogeneous population of peptide-stimulated PBMCs enabled rapid selection of high avidity tumor-reactive CTL clones, which retained their functional and tetramerhigh phenotype on re-expansion. These results demonstrate that the avidity of a T cell for its tumor target is due to the specific affinity of the TCR for its peptide-MHC ligand, that this interaction can be described using peptide-MHC tetramers and used to isolate high avidity tumor-reactive CTL.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544
Self-citationRosenberg, S. A., Yang, J. C., Schwartzentruber, D. J., Hwu, P., Marincola, F. M., Topalian, S. L., Restifo, N. P., Dudley, M. E., Schwarz, S. L., Spiess, P. J., et al. (1998) · Nature Medicine · doi:10.1038/nm0398-321 · Cited by 1,784
Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D., & Riddell, S. R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510193331603 · Cited by 1,771
Self-citationKawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Rivoltini, L., Topalian, S. L., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3515 · Cited by 1,092
HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., López-Botet, M., & Geraghty, D. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5199 · Cited by 1,053
Kawakami, Y., Eliyahu, S., Delgado, C. H., Robbins, P. F., Sakaguchi, K., Appella, E., Yannelli, J. R., Adema, G. J., Miki, T., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6458 · Cited by 914
Coulie, P. G., Brichard, V, Van Pel, A., Wölfel, T., Schneider, J., Traversari, C., Mattei, S., De Plaen, E., Lurquin, C., Szikora, J. P., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.35 · Cited by 903
Callan, M. F. C., Tan, L., Annels, N., Ogg, G. S., Wilson, J. D. K., O'Callaghan, C. A., Steven, N., McMichael, A. J., & Rickinson, A. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1395 · Cited by 892
Gallimore, A., Glithero, A., Godkin, A., Tissot, A. C., Plückthun, A., Elliott, T., Hengartner, H., & Zinkernagel, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1383 · Cited by 763
Evidence for a differential avidity model of T cell selection in the thymus
Ashton-Rickardt, P. G., Bandeira, A., Delaney, J. R., Van Kaer, L., Pircher, H.-P., Zinkernagel, R. M., & Tonegawa, S. (1994) · Cell · doi:10.1016/0092-8674(94)90505-3 · Cited by 668
T-cell-receptor affinity and thymocyte positive selection
Alam, S. M., Travers, P. J., Wung, J. L., Nasholds, W., Redpath, S., Jameson, S. C., & Gascoigne, N. R. J. (1996) · Nature · doi:10.1038/381616a0 · Cited by 609
Schatz, P. J. (1993) · Nature Biotechnology · doi:10.1038/nbt1093-1138 · Cited by 580
Kawakami, Y., Eliyahu, S., Jennings, C., Sakaguchi, K., Kang, X., Southwood, S., Robbins, P. F., Sette, A., Appella, E., & Rosenberg, S. A. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3961 · Cited by 540
Coordinate Regulation of Complex T Cell Populations Responding to Bacterial Infection
Busch, D. H., Pilip, I. M., Vijh, S., & Pamer, E. G. (1998) · Immunity · doi:10.1016/s1074-7613(00)80540-3 · Cited by 508
Alexander-Miller, M. A., Leggatt, G. R., & Berzofsky, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4102 · Cited by 501
Crawford, F., Kozono, H., White, J., Marrack, P., & Kappler, J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80572-5 · Cited by 459
Cancer antigens: immune recognition of self and altered self.
Houghton, A. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.1 · Cited by 420
Mukherji, B., Chakraborty, N. G., Yamasaki, S., Okino, T., Yamase, H., Sporn, J. R., Kurtzman, S. K., Ergin, M. T., Ozols, J., & Meehan, J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.8078 · Cited by 326
Celis, E., Tsai, V, Crimi, C., DeMars, R., Wentworth, P. A., Chesnut, R. W., Grey, H. M., Sette, A., & Serra, H. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.6.2105 · Cited by 306
Rivoltini, L., Kawakami, Y., Sakaguchi, K., Southwood, S., Sette, A., Robbins, P. F., Marincola, F. M., Salgaller, M. L., Yannelli, J. R., Appella, E., et al. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.5.2257 · Cited by 290
Enhancement of cellular immunity in melanoma patients immunized with a peptide from MART-1/Melan A.
Cormier, J. N., Salgaller, M. L., Prevette, T., Barracchini, K. C., Rivoltini, L., Restifo, N. P., Rosenberg, S. A., & Marincola, F. M. (1997) · PubMed · Cited by 277
McMichael, A. J., & O'Callaghan, C. A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1367 · Cited by 263
Kuroda, M. J., Schmitz, J. E., Barouch, D. H., Craiu, A., Allen, T. M., Sette, A., Watkins, D. I., Forman, M. A., & Letvin, N. L. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1373 · Cited by 262
Tolerance to p53 by A2.1-restricted Cytotoxic T Lymphocytes
Theobald, M., Biggs, J., Hernández, J., Lustgarten, J., Labadie, C., & Sherman, L. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.5.833 · Cited by 256
Alexander-Miller, M. A., Leggatt, G. R., Sarin, A., & Berzofsky, J. A. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.485 · Cited by 222
Salgaller, M. L., Marincola, F. M., Cormier, J. N., & Rosenberg, S. A. (1996) · PubMed · Cited by 208
Immunophenotyping of melanomas for tyrosinase: implications for vaccine development.
Chen, Y. T., Stockert, E., Tsang, S., Coplan, K. A., & Old, L. J. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.18.8125 · Cited by 176
Tsai, V, Southwood, S., Sidney, J., Sakaguchi, K., Kawakami, Y., Appella, E., Sette, A., & Celis, E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.4.1796 · Cited by 175
Hu, X., Chakraborty, N. G., Sporn, J., Kurtzman, S. H., Ergin, M. T., & Mukherji, B. (1996) · PubMed · Cited by 149
Gervois, N., Guilloux, Y., Diez, E., & Jotereau, F. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.5.2403 · Cited by 122
Update: The Numbers Game for Virus-Specific CD8 + T Cells
Doherty, P. C. (1998) · Science · doi:10.1126/science.280.5361.227 · Cited by 87
Novel methods to monitor antigen-specific cytotoxic T-cell responses in cancer immunotherapy
Romero, P. J., Cerottini, J., & Waanders, G. A. (1998) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01280-5 · Cited by 84
The new vaccines: building viruses that elicit antitumor immunity
Restifo, N. P. (1996) · Current Opinion in Immunology · doi:10.1016/s0952-7915(96)80082-3 · Cited by 68
Shilyansky, J., Nishimura, M. I., Yannelli, J. R., Kawakami, Y., Jacknin, L., Charmley, P., & Rosenberg, S. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2829 · Cited by 65
Cole, D. J., Weil, D. P., Shamamian, P. E., Rivoltini, L., Kawakami, Y., Topalian, S. L., Jennings, C., Eliyahu, S., Rosenberg, S. A., & Nishimura, M. I. (1994) · PubMed · Cited by 63
Enumeration and Characterization of Memory Cells in the TH Compartment
McHeyzer‐Williams, M. G., Altman, J. D., & Davis, M. M. (1996) · Immunological Reviews · doi:10.1111/j.1600-065x.1996.tb00693.x · Cited by 52
Self-citationCole, D. J., Wilson, M. C., Rivoltini, L., Custer, M. C., & Nishimura, M. I. (1997) · PubMed · Cited by 29
Cited by
Reits, E. A., Hodge, J. W., Herberts, C. A., Groothuis, T. A., Chakraborty, M., K.Wansley, E., Camphausen, K., Luiten, R. M., de Ru, A. H., Neijssen, J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052494 · Cited by 1,737
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
Groh, V., Wu, J., Yee, C., & Spies, T. (2002) · Nature · doi:10.1038/nature01112 · Cited by 1,592
Self-citationYee, C., Thompson, J. A., Byrd, D., Riddell, S. R., Roche, P., Celis, E., & Greenberg, P. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242600099 · Cited by 1,206
Self-citationTranslating Stem and Progenitor Cell Biology to the Clinic: Barriers and Opportunities
Weissman, I. L. (2000) · Science · doi:10.1126/science.287.5457.1442 · Cited by 852
Maus, M. V., Thomas, A. K., Leonard, D. G. B., Allman, D., Addya, K., Schlienger, K., Riley, J. L., & June, C. H. (2002) · Nature Biotechnology · doi:10.1038/nbt0202-143 · Cited by 454
Metadata
- Authors
- Yee, C., Savage, P. A., Lee, P. P., Davis, M. M., & Greenberg, P. D.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-02
- Volume
- 162
- Issue
- 4
- Pages
- 2227-2234
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1589097025
- Cited by
- 415
- References
- 37
- FWCI
- 13.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.